 "hospital, beds, patients, doctors, nurses, health care, health workers, coronavirus, testing, vaccine")
Vaccine maker Bharat Biotech and Thomas Jefferson University of Philadelphia have signed an exclusive deal to develop a new vaccine candidate for Covid-19.
The novel vaccine was developed using an existing deactivated rabies vaccine as a vehicle for coronanvirus proteins, according to Bharat Biotech. Earlier in April, the Hyderabad-based company had partnered with University of Wisconsin-Madison and US-based vaccine developer FluGen to develop a vaccine for Covid-19 called Coro-Flu.
The latest deal involves a vaccine candidate developed by infectious disease expert Matthias Schnell's lab in January this year. Recently tested on animals, the vaccine showed a strong antibody response in mice, according
